BIO recently generated a letter to the PTO on the March 6th Guidelines on the patent-eligibility of subject matter in the life sciences, particularly “natural products.” BIO invited a group of in-house and private practitioners to comment on the Guidelines and a number of them – including myself – signed off on the letter. Following appearances [...]
The post BIO Provides Supplemental Comments on PTO s.101 Guidelines appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.